Zone du titre et de la mention de responsabilité
Titre propre
Veterinary Infectious Disease Organization - Official Opening
Dénomination générale des documents
- Document graphique
Titre parallèle
Compléments du titre
Mentions de responsabilité du titre
Notes du titre
Niveau de description
Pièce
Cote
Zone de l'édition
Mention d'édition
Mentions de responsabilité relatives à l'édition
Zone des précisions relatives à la catégorie de documents
Mention d'échelle (cartographique)
Mention de projection (cartographique)
Mention des coordonnées (cartographiques)
Mention d'échelle (architecturale)
Juridiction responsable et dénomination (philatélique)
Zone des dates de production
Date(s)
-
Oct. 1978 (Production)
Zone de description matérielle
Description matérielle
1 photograph : b&w-drymounted ; 8 x 8 cm
Zone de la collection
Titre propre de la collection
Titres parallèles de la collection
Compléments du titre de la collection
Mention de responsabilité relative à la collection
Numérotation à l'intérieur de la collection
Note sur la collection
Zone de la description archivistique
Nom du producteur
Historique de la conservation
Portée et contenu
Note on back: "Jack McFaull (left), of the University Board of Governors, presents the key to the new building housing the Veterinary Infectious Disease Organization (VIDO) to Dr. Chris Bigland, director of VIDO, at the official opening of the new building".
Bio/Historical Note: The Vaccine and Infectious Disease Organization (VIDO) is a research organization of the University of Saskatchewan that operates with financial support from the Government of Canada, the government of Saskatchewan, livestock industry councils and agencies, foundations and human and animal health companies.VIDO worked to find cures for common infectious diseases in cattle, swine and poultry. VIDO scientists carved out an international reputation for their pioneering work in the 1980's on vaccines aimed at combating shipping fever and a disease which produces pneumonia and arthritis in cattle. In addition to the 2,500,000 sq ft facility on campus, VIDO-InterVac also operates a 160-acre research station. The laboratory took on its current name, International Vaccine Centre (VIDO-InterVac), in March 2003. In October 2003 a large expansion was completed. In March 2004, VIDO received funding for the construction one of the world's largest and most advanced biosafety level 3 facilities, the International Vaccine Centre (InterVac), for research into emerging and reemerging human and animal diseases. In 2020, VIDO-InterVac began developing a vaccine for SARS-CoV-2 during the COVID-19 pandemic.
Zone des notes
État de conservation
Source immédiate d'acquisition
Classement
Langue des documents
Écriture des documents
Localisation des originaux
Disponibilité d'autres formats
Restrictions d'accès
Délais d'utilisation, de reproduction et de publication
Photographer: Gibson
Copyright holder: University of Saskatchewan
Copyright holder - notes: Copyright transferred at time of donation 1992.
Copyright expires: 2028
Other terms: Responsibility regarding questions of copyright that may arise in the use of any images is assumed by the researcher.
Instruments de recherche
Éléments associés
Accruals
Location note
Vol. 75